Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
5 - 10
General Information
Version
7.1
Revision date
2023-05-18
Product name
ULTRAGUARD BX 2000
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec Industrial
Manufacturer Name
ROCOL a division of ITW Ltd
Emergency telephone
+44 (0)113 232 2600, 0344 892 0111
Icons in SDS
Company Information
company name
ROCOL a division of ITW Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@rocol.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H302+H312+H332, H312, H314, H317, H318, H332, H335, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
1,2-BENZISOTHIAZOLIN-3-ONE; 2-METHYLPENTANE-1,5-DIAMINE
Hazard statements
H302+H312+H332 - Harmful if swallowed, in contact with skin or if inhaled. H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H335 - May cause respiratory irritation. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands thoroughly after handling. P280 - Wear protective clothing, eye protection, face protection, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Acute toxicity (dermal), Category 4 H312 Acute toxicity (inhalation:vapour) Category 4 H332 Skin corrosion/irritation, Category 1, Sub-Category 1A H314 Serious eye damage/eye irritation, Category 1 H318 Skin sensitisation, Category 1 H317 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available